New Risk • Jul 08
New minor risk - Dividend sustainability The company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 1.3% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Jun 16
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩35,800, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 197% over the past three years. Price Target Changed • Jun 08
Price target increased by 9.2% to ₩57,000 Up from ₩52,200, the current price target is an average from 5 analysts. New target price is 93% above last closing price of ₩29,600. Stock is up 42% over the past year. The company is forecast to post earnings per share of ₩2,450 for next year compared to ₩2,043 last year. Valuation Update With 7 Day Price Move • May 15
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₩38,750, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 267% over the past three years. Valuation Update With 7 Day Price Move • Apr 14
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩50,000, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 328% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩80,866 per share. Valuation Update With 7 Day Price Move • Mar 27
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to ₩40,350, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 239% over the past three years. Valuation Update With 7 Day Price Move • Mar 11
Investor sentiment improves as stock rises 30% After last week's 30% share price gain to ₩47,150, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 350% over the past three years. Anuncio • Mar 06
Hankuk Carbon Co., Ltd., Annual General Meeting, Mar 27, 2026 Hankuk Carbon Co., Ltd., Annual General Meeting, Mar 27, 2026, at 08:00 Tokyo Standard Time. Location: auditorium, 85, chunhwa-ro, bubuk-myeon, gyeongsangnam-do, miryang South Korea Valuation Update With 7 Day Price Move • Feb 23
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩40,900, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 272% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩69,776 per share. Valuation Update With 7 Day Price Move • Jan 09
Investor sentiment improves as stock rises 38% After last week's 38% share price gain to ₩38,250, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 260% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩69,419 per share. Upcoming Dividend • Dec 22
Upcoming dividend of ₩130 per share Eligible shareholders must have bought the stock before 29 December 2025. Payment date: 17 April 2026. Payout ratio is a comfortable 9.7% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.3%). Buy Or Sell Opportunity • Dec 22
Now 21% undervalued Over the last 90 days, the stock has risen 3.6% to ₩33,000. The fair value is estimated to be ₩41,664, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 30% over the last 3 years. Earnings per share has grown by 63%. For the next 3 years, revenue is forecast to grow by 6.3% per annum. Earnings are also forecast to grow by 25% per annum over the same time period. Price Target Changed • Nov 19
Price target increased by 17% to ₩36,800 Up from ₩31,400, the current price target is an average from 5 analysts. New target price is 34% above last closing price of ₩27,400. Stock is up 147% over the past year. The company is forecast to post earnings per share of ₩1,845 for next year compared to ₩413 last year. Declared Dividend • Nov 08
Dividend of ₩130 announced Dividend of ₩130 is the same as last year. Ex-date: 29th December 2025 Payment date: 17th April 2026 Dividend yield will be 0.4%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 10%. Cash payout ratio: 7%. Anuncio • Nov 07
Hankuk Carbon Co., Ltd. announces Annual dividend, payable on April 17, 2026 Hankuk Carbon Co., Ltd. announced Annual dividend of KRW 130.0000 per share payable on April 17, 2026, ex-date on December 29, 2025 and record date on December 31, 2025. New Risk • Oct 15
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩38,500, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 255% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩15,756 per share. Major Estimate Revision • Sep 05
Consensus EPS estimates increase by 17% The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from ₩1,743 to ₩2,044. Revenue forecast unchanged at ₩918.4m. Net income forecast to grow 52% next year vs 47% growth forecast for Chemicals industry in South Korea. Consensus price target broadly unchanged at ₩32,000. Share price was steady at ₩33,250 over the past week. Valuation Update With 7 Day Price Move • Jun 16
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩23,950, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 89% over the past three years. Major Estimate Revision • May 17
Consensus EPS estimates increase by 66% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has improved. 2025 revenue forecast increased from ₩832.8m to ₩895.7m. EPS estimate increased from ₩937 to ₩1,552 per share. Net income forecast to grow 299% next year vs 38% growth forecast for Chemicals industry in South Korea. Consensus price target up from ₩20,250 to ₩21,750. Share price fell 3.1% to ₩20,400 over the past week. Price Target Changed • Apr 12
Price target increased by 14% to ₩18,000 Up from ₩15,825, the current price target is an average from 4 analysts. New target price is 5.5% below last closing price of ₩19,050. Stock is up 81% over the past year. The company is forecast to post earnings per share of ₩989 for next year compared to ₩413 last year. Anuncio • Apr 03
Hankuk Carbon Co., Ltd. announced that it has received KRW 39.8835 billion in funding On April 2, 2025, Hankuk Carbon Co., Ltd. closed the transaction. Valuation Update With 7 Day Price Move • Apr 03
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₩16,480, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 56% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩9,489 per share. Reported Earnings • Mar 25
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: EPS: ₩413 (up from ₩305 loss in FY 2023). Revenue: ₩741.7b (up 25% from FY 2023). Net income: ₩20.3b (up ₩33.8b from FY 2023). Profit margin: 2.7% (up from net loss in FY 2023). Revenue missed analyst estimates by 4.8%. Earnings per share (EPS) also missed analyst estimates by 35%. Revenue is forecast to grow 6.0% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings. Anuncio • Mar 13
Hankuk Carbon Co., Ltd., Annual General Meeting, Mar 27, 2025 Hankuk Carbon Co., Ltd., Annual General Meeting, Mar 27, 2025, at 09:01 Tokyo Standard Time. Location: conference room, 85, chunhwa-ro, bubuk-myeon, gyeongsangnam-do, miryang South Korea Upcoming Dividend • Dec 20
Upcoming dividend of ₩110 per share Eligible shareholders must have bought the stock before 27 December 2024. Payment date: 25 April 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 1.0%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (2.2%). Declared Dividend • Nov 13
Dividend of ₩110 announced Shareholders will receive a dividend of ₩110. Ex-date: 27th December 2024 Payment date: 25th April 2025 Dividend yield will be 1.0%, which is lower than the industry average of 1.7%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (5% cash payout ratio). The dividend has increased by an average of 1.9% per year over the past 5 years. However, payments have been volatile during that time. Major Estimate Revision • Jan 26
Consensus EPS estimates fall by 26% The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from ₩400 to ₩298 per share. Revenue forecast steady at ₩533.1m. Net income forecast to grow 134% next year vs 73% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩15,620 unchanged from last update. Share price was steady at ₩10,900 over the past week. Upcoming Dividend • Dec 20
Upcoming dividend of ₩130 per share at 1.1% yield Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 26 April 2024. Payout ratio is a comfortable 43% but the company is paying out more than the cash it is generating. Trailing yield: 1.1%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%). Price Target Changed • Nov 15
Price target increased by 9.9% to ₩16,900 Up from ₩15,375, the current price target is an average from 4 analysts. New target price is 43% above last closing price of ₩11,780. Stock is down 6.1% over the past year. The company is forecast to post earnings per share of ₩565 for next year compared to ₩471 last year. New Risk • Oct 20
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 18% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Shareholders have been diluted in the past year (18% increase in shares outstanding). Major Estimate Revision • Aug 14
Consensus EPS estimates fall by 49%, revenue upgraded The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from ₩482.4m to ₩511.9m. EPS estimate fell from ₩1,033 to ₩525 per share. Net income forecast to grow 107% next year vs 29% growth forecast for Chemicals industry in South Korea. Consensus price target up from ₩15,375 to ₩16,025. Share price fell 2.6% to ₩13,810 over the past week. Valuation Update With 7 Day Price Move • Jul 13
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩13,640, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 68% over the past three years. Major Estimate Revision • May 17
Consensus revenue estimates decrease by 14% The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from ₩543.4m to ₩468.5m. EPS estimate reaffirmed at ₩1,033. Net income forecast to grow 149% next year vs 35% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩17,450 to ₩16,625. Share price fell 5.2% to ₩10,900 over the past week. Reported Earnings • Mar 26
Full year 2022 earnings: EPS exceeds analyst expectations Full year 2022 results: EPS: ₩471 (up from ₩334 in FY 2021). Revenue: ₩369.3b (flat on FY 2021). Net income: ₩20.3b (up 41% from FY 2021). Profit margin: 5.5% (up from 3.9% in FY 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 24%. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has increased by 27% per year, which means it is well ahead of earnings. Upcoming Dividend • Dec 21
Upcoming dividend of ₩150 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 1.3%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (2.4%). Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. 3 independent directors (8 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Sep 29
Investor sentiment deteriorated over the past week After last week's 15% share price decline to ₩11,850, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 50% over the past three years. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. 3 independent directors (8 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Apr 13
Investor sentiment improved over the past week After last week's 15% share price gain to ₩12,600, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 66% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩22,996 per share. Buying Opportunity • Jan 26
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 17%. The fair value is estimated to be ₩13,543, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 25% per annum over the last 3 years. The company has become profitable over the last 3 years. Upcoming Dividend • Dec 22
Upcoming dividend of ₩180 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 13 April 2022. Payout ratio is a comfortable 24% but the company is not cash flow positive. Trailing yield: 1.7%. Lower than top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (1.5%). Major Estimate Revision • May 26
Consensus EPS estimates fall to ₩747 The consensus outlook for earnings per share (EPS) in 2021 has deteriorated. 2021 revenue forecast decreased from ₩405.1m to ₩386.7m. EPS estimate also fell from ₩1,256 to ₩747. Net income forecast to shrink 35% next year vs 72% growth forecast for Chemicals industry in South Korea . Consensus price target down from ₩15,250 to ₩14,750. Share price was steady at ₩11,600 over the past week. Price Target Changed • Mar 23
Price target increased to ₩15,250 Up from ₩13,800, the current price target is an average from 4 analysts. New target price is 30% above last closing price of ₩11,750. Stock is up 151% over the past year. Anuncio • Mar 13
Hankuk Carbon Co., Ltd., Annual General Meeting, Mar 30, 2021 Hankuk Carbon Co., Ltd., Annual General Meeting, Mar 30, 2021, at 09:00 Korea Standard Time. Is New 90 Day High Low • Mar 05
New 90-day low: ₩11,100 The company is down 13% from its price of ₩12,700 on 04 December 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩14,309 per share. Upcoming Dividend • Dec 22
Upcoming Dividend of ₩120 Per Share Will be paid on the 10th of April to those who are registered shareholders by the 29th of December. The trailing yield of 0.9% is below the top quartile of South Korean dividend payers (2.6%), but is in line with industry peers (0.9%). Is New 90 Day High Low • Dec 22
New 90-day high: ₩13,400 The company is up 45% from its price of ₩9,240 on 23 September 2020. The South Korean market is up 18% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 24% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩12,036 per share. Valuation Update With 7 Day Price Move • Nov 25
Market bids up stock over the past week After last week's 18% share price gain to ₩13,350, the stock is trading at a trailing P/E ratio of 12.8x, up from the previous P/E ratio of 10.9x. This compares to an average P/E of 13x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 148%. Price Target Changed • Nov 17
Price target raised to ₩12,250 Up from ₩11,250, the current price target is an average from 3 analysts. The new target price is close to the current share price of ₩11,700. As of last close, the stock is up 58% over the past year. Is New 90 Day High Low • Nov 13
New 90-day high: ₩11,100 The company is up 28% from its price of ₩8,660 on 14 August 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩8,152 per share. Is New 90 Day High Low • Oct 21
New 90-day high: ₩11,000 The company is up 32% from its price of ₩8,330 on 23 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩11,337 per share. 
